Suggestions
Sandra Gass
Business Development / Rare diseases / Early Commercial Strategy & Launch
Sandra Gass, Director of Business Development at Alexion Pharmaceuticals, Inc.
Sandra Gass is currently the Director of Business Development at Alexion Pharmaceuticals, Inc. based in Zurich, Switzerland.235 She has experience in rare diseases and early commercial strategy & launch.24
Gass received her education from IMD Business School.24 Prior to her current role at Alexion, she held positions such as Senior Manager, Global Corporate and Purchasing at DKT International.5
Alexion Pharmaceuticals, Inc. is a global biopharmaceutical company focused on developing therapies for patients with severe and life-threatening rare diseases.1 As Director of Business Development, Gass likely plays a key role in identifying and evaluating potential business opportunities to expand Alexion's rare disease pipeline and portfolio.